Subhash Kapre

Inventprise is led by Founder and CEO, Subhash Kapre, PhD. His experience encompasses multiple senior executive vice president positions at Serum Institute of India Pvt. Ltd. (SIIPL), which measured by volume, is the world’s largest vaccine manufacturer. During his four-decade tenure at SIIPL, Subhash held multiple functional leadership positions in R&D, manufacturing, and vaccine discovery. He is a thought leader in rDNA technology, an internationally renowned expert in both bacterial and viral vaccines and has led certification of WHO- Prequalification (regulatory approval) for large scale manufacturing.He held board positions at Akorn, and Serum Institute of India, where he was board, executive director. Subhash has a history of driving multiple vaccines from discovery, into development and through licensure for infectious diseases, including MenAfriVac® and Pneumosil®, conjugate vaccines which together will represent over 500M aggregate doses delivered by 2022. Subhash holds over 70 patents and founded Inventprise in 2012 to continue his career long mission to provide vaccines for those most in need.